Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED

Description

To Determine the feasibility, compliance and adherence to PreFED intervention in resectable melanoma patients initiating neoadjuvant Ipi/Nivo.

Conditions

Melanoma

Study Overview

Study Details

Study overview

To Determine the feasibility, compliance and adherence to PreFED intervention in resectable melanoma patients initiating neoadjuvant Ipi/Nivo.

Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED

Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED

Condition
Melanoma
Intervention / Treatment

-

Contacts and Locations

Houston

MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age ≥ 18 years old.
  • 2. Body mass index (BMI) 18.5-45 kg/m2
  • 3. English-speaking
  • 4. ECOG performance status of 0 or 1
  • 5. Histologically confirmed resectable stage IIIB-D or oligometastatic Stage IV cutaneous melanoma or locally invasive/advanced mucosal melanoma as determined by multidisciplinary review
  • 6. Planned initiation of standard-of-care neoadjuvant Ipilimumab + Nivolumab or Nivolumab + Relatlimab
  • 7. Measurable disease per RECIST 1.1
  • 8. WOCP must have negative UPT within 1 week of beginning dietary intervention.
  • 9. Self-reported willingness to eat the provided foods (with some tailoring to their food preferences)
  • 10. Self-reported willingness to comply with scheduled visits, undergo venipuncture, provide stool samples.
  • 11. Archival tissue specimen or planned to undergo tumor biopsy as part of standard of care treatment.
  • 1. Uveal melanoma
  • 2. History of inflammatory bowel disease, total colectomy, or bariatric surgery
  • 3. Currently taking steroids \> Prednisone 10 mg/day or equivalent
  • 4. Medical contraindications to the Intervention Diet as determined by the treating physician.
  • 5. Self-reported major dietary restrictions, including but not limited to relevant food allergies, celiac disease, or diets such as vegan, ketogenic, extended fasting.
  • 6. Insulin-dependent diabetes or conditions requiring bile-acid sequestrants
  • 7. Unable or unwilling to undergo study procedures.
  • 8. IV antibiotic use in the past month or oral antibiotic use in past 2 weeks
  • 9. Regularly taking supplements containing prebiotics, fiber and/or probiotics, and unable/unwilling to discontinue for the purpose of the study
  • 10. Current smoker or heavy drinker (defined as \>14 drinks per week) or current illicit drug use
  • 11. Currently pregnant, planning to become pregnant, or lactating
  • 12. Concurrent malignancy requiring systemic therapy other than hormonal therapy
  • 13. Cognitively impaired adults

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Jennifer McQuade, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2030-09-01